Gilead Rode An Unexpected Source For Its Sales Beat, But Profit Came Up Short

Gilead came up with a mixed fourth quarter late Tuesday as sales of its Covid treatment bolstered sales. GILD stock slipped in late trades. The post Gilead Rode An Unexpected Source For Its Sales Beat, But Profit Came Up Short appeared first on Investor's Business Daily.#gild
Source: Reuters: Health - Category: Consumer Health News Source Type: news